Novo Nordisk announced it will deploy Anthropic's Claude models across R&D workflows, with CEO Mike Doustdar saying it will 'supercharge our R&D organisation.' No contract value, model tier or deployment timeline was disclosed. Single-source at time of writing via the aggregator's citation of novonordisk.com; the company newsroom index did not surface the release on fetch.